E. Jeffrey North - Concepedia

Author

E. Jeffrey North

Also Known As

E. J. North, E. Jeffrey North, E. North, E.J. North, ELTON NORTH, Eldon Jeffrey North, Eleanor North, Elisabeth North, Elton J North, Elton J. North

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Colorado State University Creighton University St. Jude Children's Research Hospital University of California, Davis Comenius University Bratislava

About

E. Jeffrey North is an author at Colorado State University specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.1K
2	Biochemistry	5	5	632
3	Engineering	3	3	103
4	Natural Sciences	3	3	169
5	Health Sciences	2	2	211

E. Jeffrey North

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane Anna E. Grzegorzewicz, Hà Phạm, Vijay A. K. B. Gundi, Nature Chemical Biology Pulmonary TuberculosisBiochemistryMembrane TransportTuberculosisMicrobiology	2012	434
Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis Wěi Li, Ashutosh Upadhyay‬, Fabio L. Fontes, Antimicrobial Agents and Chemotherapy ImmunologyAntimicrobial ChemotherapyDrug ResistanceMycolic AcidsOuter Membrane	2014	198
Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3 Wěi Li, Andrés Obregón‐Henao, Joshua B. Wallach, Antimicrobial Agents and Chemotherapy	2016	117
The structure–activity relationship of urea derivatives as anti-tuberculosis agents Joshua R. Brown, E. Jeffrey North, Julian G. Hurdle, Bioorganic & Medicinal Chemistry MedicineUrea DerivativesTuberculosisAntibacterial AgentAntimicrobial Compound	2011	105
Direct Inhibition of MmpL3 by Novel Antitubercular Compounds Wei Li, Casey M. Stevens, Amitkumar N. Pandya, ACS Infectious Diseases Molecular BiologyDirect InhibitionChemical BiologyPharmaceutical ChemistryDrug Resistance	2019	96
Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties E. Jeffrey North, Michaël Scherman, David F. Bruhn, Bioorganic & Medicinal Chemistry UrologyMedicineAntibacterial AgentAnti-tuberculosis ActivityPharmacology	2013	80
Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability Michaël Scherman, E. Jeffrey North, Victoria Jones, Bioorganic & Medicinal Chemistry Pulmonary TuberculosisAnti-mycobacterium Tuberculosis ActivityBiotechnologyTuberculosisAntibacterial Agent	2012	78
Preparation, Characterization, and In vitro Evaluation of Curcumin- and Resveratrol-Loaded Solid Lipid Nanoparticles Ashwini Gumireddy, Ryann M. Christman, Dunesh Kumari, AAPS PharmSciTech NanoparticlesNanomedicineLipid PreparationEngineeringNano-drug Delivery	2019	77
Design, synthesis and evaluation of indole-2-carboxamides with pan anti-mycobacterial activity Nicholas D. Franz, Juan M. Belardinelli, Michael A. Kaminski, Bioorganic & Medicinal Chemistry Pan Anti-mycobacterial ActivityAntibacterial AgentAntimicrobial ChemotherapyAntimicrobial CompoundPharmacology	2017	67
Covalent Modification of the <i>Mycobacterium tuberculosis</i> FAS-II Dehydratase by Isoxyl and Thiacetazone Anna E. Grzegorzewicz, Nathalie Eynard, Annaı̈k Quémard, ACS Infectious Diseases	2014	66

Page 1